510(k) device
StrokeSENS ASPECTS Software Application
Circle Cardiovascular Imaging, Inc. · Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK, Class II) · First FDA decision Jul 1, 2025, newest Jul 1, 2025Breast cancerCancer detection and genomic testingThyroid nodules and thyroid disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "StrokeSENS ASPECTS"
MAUDE reports
0
Brand "StrokeSENS ASPECTS", since 2015
PubMed studies
1
Mentioning "StrokeSENS ASPECTS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing StrokeSENS ASPECTS Software Application
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K250221 · Decided Jul 1, 2025 · 158 days after receipt
Device type: Computer-Assisted Diagnostic Software For Lesions Suspicious For Cancer (POK) · Radiology & Imaging
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "StrokeSENS ASPECTS", any status and sponsor, newest update first.
University Hospital of North NorwayAcademic, hospital or other
NCT05903898 · 1,000 participants (planned) · Start Jun 1, 2023 · Primary completion Oct 31, 2025
Device: AI software StrokeSens (Circle NVI) · For: Ischemic Stroke
Sites: Tromsø, Norway
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "StrokeSENS ASPECTS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POK
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "StrokeSENS ASPECTS"[tiab]. The summary above synthesizes these.
- Validation of an Automated ASPECTS Software via a Multi-Reader Multi-Case Clinical Reader Study.
Golan R, Duarte KTN, Duszynski CC, et al. · AJNR Am J Neuroradiol · 2026
Other devices of this type
Also filed under product code POK.
- Koios DS (3.8)Koios Medical, Inc. · 510(k) 2026
- Fetal EchoScan (v1.2)Brightheart · 510(k) 2025
- Sonio SuspectSonio · 510(k) 2026
- Brainomix 360 e-ASPECTSBrainomix Limited · 510(k) 2025
- Rapid ASPECTS (v3)Ischemaview, Inc. · 510(k) 2024
- BlineSlideDeep Breathe, Inc. · 510(k) 2026
- Automated Aortic Stenosis Software (AutoAS)GE Medical Systems Ultrasound & Primary Care Diagnostics, LLC · 510(k) 2026
- RevealAI-LungPrecision Medical Ventures, Inc. Dba Revealdx · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.